-
EP2405898
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2405898
| EP2405898 - SUSTAINED RELEASE COMPOSITION OF THERAPEUTIC AGENT [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.06.2016 Database last updated on 03.06.2024 | Most recent event Tooltip | 03.06.2016 | Application deemed to be withdrawn | published on 06.07.2016 [2016/27] | Applicant(s) | For all designated states COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH Anusandhan Bhawan Rafi Marg New Delhi 110001 / IN | [2012/03] | Inventor(s) | 01 /
MUTHUSAMY, Ramesh National Chemical Laboratory Dr . Homi Bhabha Road Pune 411008 Maharashtra / IN | 02 /
KULKARNI, Mohan, Gopalkrishna National Chemical Laboratory Dr . Homi Bhabha Road Pune 411008 Maharashtra / IN | [2012/03] | Representative(s) | Srinivasan, Ravi Chandran J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | [N/P] |
| Former [2012/03] | Srinivasan, Ravi Chandran J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 10713366.2 | 05.03.2010 | WO2010IB00459 | Priority number, date | INDE04532009 | 09.03.2009 Original published format: IN DE04532009 | [2012/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2010103365 | Date: | 16.09.2010 | Language: | EN | [2010/37] | Type: | A2 Application without search report | No.: | EP2405898 | Date: | 18.01.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.09.2010 takes the place of the publication of the European patent application. | [2012/03] | Search report(s) | International search report - published on: | EP | 18.11.2010 | Classification | IPC: | A61K9/20, A61K9/28, A61K47/34 | [2012/03] | CPC: |
A61K47/34 (EP,US);
A61K31/167 (EP,US);
A61K31/192 (EP,US);
A61K31/522 (EP,US);
A61K31/545 (EP,US);
A61K31/554 (EP,US);
A61K9/2853 (EP,US);
A61P11/06 (EP);
A61P29/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/03] | Title | German: | ZUSAMMENSETZUNG MIT ANHALTENDER FREISETZUNG EINES THERAPEUTIKUMS | [2012/03] | English: | SUSTAINED RELEASE COMPOSITION OF THERAPEUTIC AGENT | [2012/03] | French: | COMPOSITION À LIBÉRATION LENTE D'UN AGENT THÉRAPEUTIQUE | [2012/03] | Entry into regional phase | 12.09.2011 | National basic fee paid | 12.09.2011 | Designation fee(s) paid | 12.09.2011 | Examination fee paid | Examination procedure | 12.09.2011 | Examination requested [2012/03] | 11.05.2012 | Amendment by applicant (claims and/or description) | 13.08.2015 | Communication of intention to grant the patent | 24.12.2015 | Application deemed to be withdrawn, date of legal effect [2016/27] | 08.02.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2016/27] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 13.08.2015 | Fees paid | Renewal fee | 30.03.2012 | Renewal fee patent year 03 | 31.12.2012 | Renewal fee patent year 04 | 29.01.2014 | Renewal fee patent year 05 | 07.01.2015 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.03.2016 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US5280089 (DEGRAAF HENRY J [US], et al) [A] 1-27 * column 3, line 40 - column 5, line 40 * * column 9, line 22 - line 27 *; | [A]US5449707 (HIGASHIURA SHINYA [JP], et al) [A] 1-27 * abstract * * column 2, line 16 - line 49 * * column 3, line 2 - column 4, line 25 * * examples A-2 * * table 1 *; | [A]US2003190362 (SACKLER RICHARD S [US], et al) [A] 1-27 * paragraph [0106] * * claims 73-77 *; | [A]US2005191349 (BOEHM GARTH [US], et al) [A] 1-27 * claims 15-17 * | by applicant | US6312724 | US5945125 | US5422123 | WO03099203 | US6569457 | US4863744 | WO2005030179 | US4968508 | US6893661 | EP1043976 | US6274173 | US2008026060 | WO0234240 | WO2007052877 | WO2007143290 | WO2004091583 | WO9748386 | - 0. S. SILVA; C. R. F. SOUZA; W. P. OLIVEIRA; S. C. S. ROCHA, DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, (2006), vol. 32, pages 661 - 667 | - GIOVANNI FILIPPO PALMIERI; SIMONA MICHELINI; PIERA DI MARTINO; SANTE MARTELLI, DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, (2000), vol. 26, pages 837 - 845 |